These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients. Ibels SL, Reardon MF, Nestel PJ. J Lab Clin Med; 1976 Apr; 87(4):648-58. PubMed ID: 775004 [Abstract] [Full Text] [Related]
11. Cardiovascular response to hemodialysis: the effects of uremia and dialysate buffer. Jaraba M, Rodríguez-Benot A, Guerrero R, del Castillo D, Martín-Malo A, Rodríguez M, Aljama P. Kidney Int Suppl; 1998 Dec; 68():S86-91. PubMed ID: 9839290 [Abstract] [Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
13. Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man. Bagdade J, Casaretto A, Albers J. J Lab Clin Med; 1976 Jan; 87(1):38-48. PubMed ID: 173766 [Abstract] [Full Text] [Related]
14. Lipid metabolism in plasma, liver, and adipose tissue of rats with experimental chronic nephrotic syndrome. Morin RJ, Davidson WD, Rorke SJ, Guo LS. Lipids; 1977 Feb; 12(2):208-14. PubMed ID: 846306 [Abstract] [Full Text] [Related]
15. Serum lipids status in patients with diabetic uremia on 10 years of maintenance hemodialysis. Sakurai T, Akiyama H, Oka T, Sekita K, Yokono K, Goto T. Kidney Int Suppl; 1999 Jul; 71():S216-8. PubMed ID: 10412780 [Abstract] [Full Text] [Related]
16. Plasma lipids and fatty acid levels in chronically uremic patients undergoing blood purification with different methods. Marangoni R, Civardi F, Savino R, Colombo R, Marangoni F, Mosconi C, Galli C. Artif Organs; 1992 Dec; 16(6):625-9. PubMed ID: 1482334 [Abstract] [Full Text] [Related]
17. Effects of 1,25 (OH)2D3 treatment on lipid levels in uremic hemodialysis patients. Yeksan M, Türk S, Polat M, Ciğli A, Erdoğan Y. Int J Artif Organs; 1992 Dec; 15(12):704-7. PubMed ID: 1493945 [Abstract] [Full Text] [Related]
18. Hemodialysis and cell toxicity in vitro related to plasma triglycerides, post-heparin lipolytic activity and free fatty acids. Wessel-Aas T, Blomhoff JP, Wirum E, Nilsen T. Acta Med Scand; 1984 Dec; 216(1):75-83. PubMed ID: 6485883 [Abstract] [Full Text] [Related]
19. Systemic heparinization of uremic patients and its effects on blood lipids and on in vitro toxicity of the plasma. Wessel-Aas T, Christophersen B. Clin Nephrol; 1982 Sep; 18(3):135-40. PubMed ID: 7140025 [Abstract] [Full Text] [Related]
20. Selective deficiency of hepatic triglyceride lipase in uremic patients. Mordasini R, Frey F, Flury W, Klose G, Greten H. N Engl J Med; 1977 Dec 22; 297(25):1362-6. PubMed ID: 200841 [Abstract] [Full Text] [Related] Page: [Next] [New Search]